Back

Early p2y12 inhibitors escalation in st segment elevation myocardial infarction: prevalence, impact on platelet production and function, and long-term prognosis

2 March 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Acute Coronary Syndromes: Biomarkers, Pharmacotherapy and Prevention Pharmacotherapy ACVC Premium Access Acute Cardiovascular Care 2019

About the speaker

Photo
Professor Lidia Malinova

Saratov State Medical University, Saratov (Russian Federation)

19 More presentations in this session

Presentation thumbnail
Acute Coronary Syndromes: Biomarkers, Pharmacotherapy and Prevention - Poster discussant - 12:45 - 13:45.
Presentation thumbnail
A novel high-sensitivity cardiac troponin i assay for early diagnosis of acute myocardial infarction
Associate Professor J. Boeddinghaus (Basel, CH)
Abstract
Presentation thumbnail
The utility of serum soluble st2 measured at discharge in prognostication of late ventricular adverse remodeling in patients with st-segment elevation myocardial infarction
Doctor O. Petyunina (Kharkiv, UA)
Presentation thumbnail
Serum microRNA-27a expression in patients with acute coronary syndrome without ST-segment elevation undergoing percutaneous coronary intervention
Presentation thumbnail
miR-1 and miR-126 concentrations in patients with acute myocardial infarction 
treated invasively.
Doctor E. Kazimierczyk (Bialystok, PL)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Acute Coronary Syndromes: Biomarkers, Pharmacotherapy and Prevention

The Event

Event poster

Acute Cardiovascular Care 2019

2 March - 4 March 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources